LexDanaLexDanabeta
Inventor

Dominique Jean-Pierre Mabire

Inventor
La Saussaye, FR

Overview

21→
Patents
1999–2015
Patent span
Human necessities
Primary field (CPC A)

Patents· 21 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations37%
C07DHeterocyclic compounds37%
A61KPreparations for medical, dental or toiletry purposes21%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C04BLime, magnesia2%
PatentTitleYear
9,115,084'6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20158,524,714'7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20138,450,486'6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20138,071,612'6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20117,928,104'7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20117,879,857'6-substituted 2-quinolinones and 2-quinoxalinones as poly (adp-ribose) polymerase inhibitors'20117,855,207'6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adpribose) polymerase inhibitors'20107,652,014'Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors'20107,629,468'Metabotropic glutamate receptor antagonists'20097,579,352'Retinoic acid mimetic anilides'20097,378,433'N-[4-(heteroarylmethyl)phenyl]-heteroarylamines'20087,205,312'N-[4-(heteroarylmethyl)phenyl]-heteroarylamines'20077,179,825'Retinoic acid mimetic anilides'20077,115,608'Pyridinone and pyridinethione derivatives having HIV inhibiting properties'20067,115,630'Metabotropic glutamate receptor antagonists'20066,936,626'Retinoic acid mimetic anilides'20056,833,375'N-4-(heteroarylmethyl)phenyl-heteroarylamines'20046,486,187'N-4-(heteroarylmethyl)phenyl-heteroarylamines'20026,319,939'Retinoic acid mimetic anlides'20016,124,330'N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines'20005,922,734'6-›triazolyl›3-(trifluoromethyl)phenyl!methyl!-2-quinolines and -quinolinethiones'1999

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1999–2015Patents assigned to JANSSEN PHARMACEUTICA NV (18)· patent assignee history
1999–2009Based in La Saussaye, FR· patent location history
2006Based in Issy les Moulineaux, FR· patent location history
2010–2013Based in La Ferté Macé, FR· patent location history
2011–2013Patents assigned to GUILLEMONT JEROME EMILE GEORGES (4)· patent assignee history
2011–2013Patents assigned to MABIRE DOMINIQUE JEAN-PIERRE (4)· patent assignee history
2011–2013Patents assigned to SOMERS MARIA VICTORINA FRANCISCA (4)· patent assignee history
2011–2013Patents assigned to VAN DUN JACOBUS ALPHONSUS JOSEPHUS (4)· patent assignee history
2013–2015Based in Val de Reuil, FR· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN PHARMACEUTICA NV181999–2015
GUILLEMONT JEROME EMILE GEORGES42011–2013
MABIRE DOMINIQUE JEAN-PIERREself42011–2013
SOMERS MARIA VICTORINA FRANCISCA42011–2013
VAN DUN JACOBUS ALPHONSUS JOSEPHUS42011–2013
Locations
LocationPatentsSpan
La Saussaye, FR121999–2009
La Ferté Macé, FR62010–2013
Val de Reuil, FR22013–2015
Issy les Moulineaux, FR12006